WOLVERINE ASSET MANAGEMENT LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 185 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$92,000
-21.4%
126,4970.0%0.00%0.0%
Q1 2020$117,000
-94.9%
126,497
-27.3%
0.00%
-96.8%
Q1 2019$2,313,000
-36.9%
174,083
-26.1%
0.03%
-29.5%
Q4 2018$3,668,000
+3175.0%
235,483
+4031.3%
0.04%
+4300.0%
Q3 2018$112,000
-92.9%
5,700
-89.7%
0.00%
-95.0%
Q2 2018$1,584,000
-51.6%
55,200
-60.1%
0.02%
-52.4%
Q1 2018$3,275,000
+75.7%
138,500
+59.4%
0.04%
+121.1%
Q4 2017$1,864,000
+74.0%
86,900
+91.8%
0.02%
+58.3%
Q3 2017$1,071,000
+21320.0%
45,300
+15000.0%
0.01%
Q2 2017$5,000
-99.7%
300
-99.7%
0.00%
-100.0%
Q1 2017$1,929,000
-52.8%
91,900
-57.7%
0.03%
-43.4%
Q4 2016$4,089,000
-21.0%
217,500
-12.3%
0.05%
-32.1%
Q3 2016$5,177,000
+137.7%
248,000
+190.4%
0.08%
+136.4%
Q2 2016$2,178,000
+329.6%
85,400
+8033.3%
0.03%
+135.7%
Q1 2016$507,0001,050
+104900.0%
0.01%
Q4 2015$0
-100.0%
1
-97.1%
0.00%
Q3 2015$20,000
+100.0%
350.0%0.00%
Q2 2015$10,000
-81.5%
35
-96.6%
0.00%
-100.0%
Q1 2015$54,000
-40.0%
1,035
+3.5%
0.00%
-50.0%
Q4 2014$90,000
-24.4%
1,000
+100.0%
0.00%0.0%
Q3 2014$119,0005000.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 325,000$8,289,0002.39%
ARMISTICE CAPITAL, LLC 232,000$5,917,0002.25%
SENZAR ASSET MANAGEMENT, LLC 358,191$9,135,662,0001.99%
SCOPIA CAPITAL MANAGEMENT LP 3,171,229$80,882,0001.67%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,029,410$26,255,0001.03%
Baker Brothers Advisors 3,661,082$93,376,0000.98%
ARBOR CAPITAL MANAGEMENT LLC 58,783$1,499,0000.79%
Spark Investment Management LLC 292,400$7,457,0000.70%
SPHERA FUNDS MANAGEMENT LTD. 98,000$2,499,0000.65%
Virtus ETF Advisers LLC 21,130$539,0000.40%
View complete list of ACORDA THERAPEUTICS INC shareholders